骨形成蛋白6(BMP6)重組蛋白
Recombinant Bone Morphogenetic Protein 6 (BMP6)
VGR; VGR1; Vegetal Related Growth Factor(TGFB-Related); VG-1-related protein
- 編號(hào)URPA646Mu02
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位n/a
- 預(yù)測(cè)分子量-
- 實(shí)際分子量-(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽N-terminal His Tag
- 緩沖液成份磷酸鹽緩沖液（pH7.4，含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)-
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 420 ¥ 1050 ¥ 2100 ¥ 6300 ¥ 15750
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
PBS或其它。
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPA646Mu02 | 骨形成蛋白6(BMP6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA646Mu01 | 骨形成蛋白6(BMP6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA646Mu01 | 骨形成蛋白6(BMP6)多克隆抗體 | WB; IHC; ICC; IP. |
| UPAA646Mu02 | 骨形成蛋白6(BMP6)多克隆抗體 | WB; IHC; ICC; IP. |
| USEA646Mu | 骨形成蛋白6(BMP6)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMA646Mu | 骨形成蛋白6(BMP6)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| International Journal of Cardiology | Valvular osteoclasts in calcification and aortic valve stenosis severity [PubMed: 23452891] |
| Polskie Archiwum Medycyny Wewn Trznej | New parameters in iron metabolism and functional iron deficiency in patients on maintenance hemodialysis [PubMed: 23111696] |
| PLoS ONE | A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches [Plosone: Source] |
| journal of biomedical materials research part b-applied biomaterials | In vitro chondrogenesis by BMP6 gene therapy [Pubmed: 23077084] |
| Journal of Clinical Pathology | Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C [PubMed: 26290259] |
| Clinical?and Experimental Pharmacology and Physiology | Bone morphogenetic protein 6—a possible new player in pathophysiology of heart failure [pubmed:27592865] |
| International Journal of Biological Macromolecules | SEQUENTIAL IGF-1 AND BMP-6 RELEASING CHITOSAN/ALGINATE/PLGA HYBRID SCAFFOLDS FOR PERIODONTAL REGENERATION [pubmed:28601648] |
| Elife | The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium [Pubmed:29749927] |
留言咨詢
